Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as…
CLC invites individual and institutional investors, as well as advisors and analysts, to attend our interactive presentation real-time on VirtualInvestorConferences.comVANCOUVER,…
VICTORIA, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil” or the “Company”) (TSXV: VGL) announced…
CAMBRIDGE, Mass., Jan. 17, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines…
MELBOURNE, Australia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on…
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as…
John Dawson to retire from Oxford Biomedica Oxford, UK – 17 January 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the…
NANTES, France, Jan. 17, 2022 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced the departure of…
Toronto, Ontario--(Newsfile Corp. - January 17, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) ("West Island"…
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Alpha Blue Ocean, the family office founded by Pierre Vannineuse, is delighted to announce the launch…